Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Logo for

Science 310 (5750): 1022-1025

Copyright © 2005 by the American Association for the Advancement of Science

Small-Molecule Inhibition of TNF-{alpha}

Molly M. He,1 Annemarie Stroustrup Smith,2 Johan D. Oslob,1 William M. Flanagan,1 Andrew C. Braisted,1 Adrian Whitty,3 Mark T. Cancilla,1 Jun Wang,4 Alexey A. Lugovskoy,3 Josh C. Yoburn,1 Amy D. Fung,1 Graham Farrington,3 John K. Eldredge,3 Eric S. Day,3 Leslie A. Cruz,5 Teresa G. Cachero,3 Stephan K. Miller,3 Jessica E. Friedman,3 Ingrid C. Choong,1 Brian C. Cunningham1*

Abstract: We have identified a small-molecule inhibitor of tumor necrosis factor {alpha} (TNF-{alpha}) that promotes subunit disassembly of this trimeric cytokine family member. The compound inhibits TNF-{alpha} activity in biochemical and cell-based assays with median inhibitory concentrations of 22 and 4.6 micromolar, respectively. Formation of an intermediate complex between the compound and the intact trimer results in a 600-fold accelerated subunit dissociation rate that leads to trimer dissociation. A structure solved by x-ray crystallography reveals that a single compound molecule displaces a subunit of the trimer to form a complex with a dimer of TNF-{alpha} subunits.

1 Sunesis Pharmaceuticals, Incorporated, 341 Oyster Point Boulevard, South San Francisco, CA 94080, USA.
2 Kravis Children's Hospital, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1198, New York, NY 10029, USA.
3 Department of Drug Discovery, BiogenIdec, 14 Cambridge Center, Cambridge, MA 02142, USA.
4 Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139–4307, USA.
5 Chemistry and Chemical Biology Program, University of California, San Francisco, 600 16th Street, Box 2280, San Francisco, CA 94143, USA.

* To whom correspondence should be addressed. E-mail: bcc{at}sunesis.com

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Homogeneous HTRF Assay for the Identification of Inhibitors of the TWEAK-Fn14 Protein Interaction.
T. Benicchi, S. Iozzi, A. Svahn, H. Axelsson, E. Mori, S. Bernocco, F. Cappelli, C. Caramelli, P. Fanti, E. Genesio, et al. (2012)
J Biomol Screen 17, 933-945
   Abstract »    Full Text »    PDF »
Perspectives on the Discovery of Small-Molecule Modulators for Epigenetic Processes.
Q. Lu, A. M. Quinn, M. P. Patel, S. F. Semus, A. P. Graves, D. Bandyopadhyay, A. J. Pope, and S. H. Thrall (2012)
J Biomol Screen 17, 555-571
   Abstract »    Full Text »    PDF »
Proline-Proline-Glutamic Acid (PPE) Protein Rv1168c of Mycobacterium tuberculosis Augments Transcription from HIV-1 Long Terminal Repeat Promoter.
K. H. Bhat, C. K. Chaitanya, N. Parveen, R. Varman, S. Ghosh, and S. Mukhopadhyay (2012)
J. Biol. Chem. 287, 16930-16946
   Abstract »    Full Text »    PDF »
A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF.
E. Douni, V. Rinotas, E. Makrinou, J. Zwerina, J. M. Penninger, E. Eliopoulos, G. Schett, and G. Kollias (2012)
Hum. Mol. Genet. 21, 784-798
   Abstract »    Full Text »    PDF »
Structural conservation of druggable hot spots in protein-protein interfaces.
D. Kozakov, D. R. Hall, G.-Y. Chuang, R. Cencic, R. Brenke, L. E. Grove, D. Beglov, J. Pelletier, A. Whitty, and S. Vajda (2011)
PNAS 108, 13528-13533
   Abstract »    Full Text »    PDF »
An Intrabody Based on a Llama Single-domain Antibody Targeting the N-terminal {alpha}-Helical Multimerization Domain of HIV-1 Rev Prevents Viral Production.
T. Vercruysse, E. Pardon, E. Vanstreels, J. Steyaert, and D. Daelemans (2010)
J. Biol. Chem. 285, 21768-21780
   Abstract »    Full Text »    PDF »
Phenothiazines inhibit S100A4 function by inducing protein oligomerization.
V. N. Malashkevich, N. G. Dulyaninova, U. A. Ramagopal, M. A. Liriano, K. M. Varney, D. Knight, M. Brenowitz, D. J. Weber, S. C. Almo, and A. R. Bresnick (2010)
PNAS 107, 8605-8610
   Abstract »    Full Text »    PDF »
Allosteric Inhibition of Human Porphobilinogen Synthase.
S. H. Lawrence, U. D. Ramirez, T. Selwood, L. Stith, and E. K. Jaffe (2009)
J. Biol. Chem. 284, 35807-35817
   Abstract »    Full Text »    PDF »
17-Acetoxyjolkinolide B irreversibly inhibits I{kappa}B kinase and induces apoptosis of tumor cells.
S.-S. Yan, Y. Li, Y. Wang, S.-S. Shen, Y. Gu, H.-B. Wang, G.-W. Qin, and Q. Yu (2008)
Mol. Cancer Ther. 7, 1523-1532
   Abstract »    Full Text »    PDF »
Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states.
Z. Zhou, X. Song, A. Berezov, G. Zhang, Y. Li, H. Zhang, R. Murali, B. Li, and M. I. Greene (2008)
PNAS 105, 5465-5470
   Abstract »    Full Text »    PDF »
Mechanism-Based Inactivation of Lung-Selective Cytochrome P450 CYP2F Enzymes.
J. S. Kartha and G. S. Yost (2008)
Drug Metab. Dispos. 36, 155-162
   Abstract »    Full Text »    PDF »
A Virus-Like Particle-Based Vaccine Selectively Targeting Soluble TNF-{alpha} Protects from Arthritis without Inducing Reactivation of Latent Tuberculosis.
G. Spohn, R. Guler, P. Johansen, I. Keller, M. Jacobs, M. Beck, F. Rohner, M. Bauer, K. Dietmeier, T. M. Kundig, et al. (2007)
J. Immunol. 178, 7450-7457
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882